Macleods Pharmaceuticals Limited recalls Macleods — Losartan Potassium/Hydrochlorothiazide Combination Tablets
- Recall date
- February 22, 2019
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- Macleods Pharmaceuticals Limited, Macleods
Why it was recalled
Due to detection of NDEA (N-Nitrosodiethylamine) Impurity — Potential Lack of Sterility
What was recalled
Losartan Potassium/Hydrochlorothiazide Combination Tablets
Read the official recall notice →
Get recall alerts
Free email alert whenever Macleods Pharmaceuticals Limited has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Macleods Pharmaceuticals Limited, Macleods